We are seeking healthy males to participate in our study.
There is no cost to participate. Those who qualify will receive up to $5,300 in compensation plus reimbursement for travel. We encourage you to review the participation requirements listed below.
Qualified participants must be:
Between the ages of 18 and 40 years old
At least 110lbs in weight
In generally good health with no diagnosed medical conditions or sleep disorders
Able and willing to:
Participate in 1 outpatient screening visit, and if eligible, 1 inpatient visit for 4-days/ 3-nights
Enroll into an add-on study with two additional 4-day/ 3-night inpatient stays after completion, if qualified and selected by the study sponsor
Wear a device on the wrist similar to a watch, if selected for the add-on study
Complete on-site pre-qualification testing including, but not limited to, ECG, urinalysis, COVID-19 screening, and bloodwork
Participants may receive compensation up to $1,750 for time and participation for the first part of this study. If selected for the add-on study, you will be compensated up to an additional $3,700 if all visits are completed. Travel reimbursement up to $80 per visit, with receipts, will also be available. Total compensation is dependent on the number of visits completed.
$150 – Outpatient Screening Visit
$350 – Inpatient Visits (per day)
$150 – Discharge of Inpatient Visits
$150 – Follow-up Visit(s)
$250 – Completion bonus ($500 max for completion of both parts in this study)
$50 – Dispensing of wrist device (add-on study only)
$50 – Daily use of wrist device (per day, max of $700, add-on study only)
$80 – Roundtrip travel visit reimbursement to Clinilabs research center, with receipts
Study Schedule:
Screening Visit, 4-day/ 3-night Inpatient Stay, Follow-Up Visit. Most eligible participants will be selected to enroll into an add-on study which includes two additional 4-day/ 3-night Inpatient Stays and a Follow-Up Visit. If selected for the add-on study, you will return within 6 weeks for the next inpatient stay. Up to 9 nights inpatient if all visits completed. Total participation 10 to 67 days.
Next Check-In Date: July 29 2024
Last Day to Screen for this Round: July 24 2024